| Real-time single-molecule imaging of the infection pathway of an adeno-associated virus G Seisenberger, MU Ried, T Endress, H Buning, M Hallek, C Brauchle Science 294 (5548), 1929-1932, 2001 | 1138 | 2001 |
| Not interferon, but interleukin‐6 controls early gene expression in hepatitis B virus infection M Hösel, M Quasdorff, K Wiegmann, D Webb, U Zedler, M Broxtermann, ... Hepatology 50 (6), 1773-1782, 2009 | 414 | 2009 |
| Gene therapy on the move KB Kaufmann, H Büning, A Galy, A Schambach, M Grez EMBO molecular medicine 5 (11), 1642-1661, 2013 | 379 | 2013 |
| HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice JA Horwitz, A Halper-Stromberg, H Mouquet, AD Gitlin, A Tretiakova, ... Proceedings of the National Academy of Sciences 110 (41), 16538-16543, 2013 | 307 | 2013 |
| Recent developments in adeno‐associated virus vector technology H Büning, L Perabo, O Coutelle, S Quadt‐Humme, M Hallek The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2008 | 304 | 2008 |
| In vitro selection of viral vectors with modified tropism: the adeno-associated virus display L Perabo, H Büning, DM Kofler, MU Ried, A Girod, CM Wendtner, ... Molecular therapy 8 (1), 151-157, 2003 | 294 | 2003 |
| Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells SA Nicklin, H Buening, KL Dishart, M De Alwis, A Girod, U Hacker, ... Molecular therapy 4 (3), 174-181, 2001 | 293 | 2001 |
| Capsid modifications for targeting and improving the efficacy of AAV vectors H Büning, A Srivastava Molecular therapy Methods & clinical development 12, 248-265, 2019 | 262 | 2019 |
| In vivo imaging reveals a phase-specific role of STAT3 during central and peripheral nervous system axon regeneration FM Bareyre, N Garzorz, C Lang, T Misgeld, H Büning, M Kerschensteiner Proceedings of the National Academy of Sciences 108 (15), 6282-6287, 2011 | 254 | 2011 |
| Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors SJ White, SA Nicklin, H Büning, MJ Brosnan, K Leike, ED Papadakis, ... Circulation 109 (4), 513-519, 2004 | 245 | 2004 |
| Restoration of cone vision in the CNGA3−/− mouse model of congenital complete lack of cone photoreceptor function S Michalakis, R Mühlfriedel, N Tanimoto, V Krishnamoorthy, S Koch, ... Molecular therapy 18 (12), 2057-2063, 2010 | 231 | 2010 |
| Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking K Lux, N Goerlitz, S Schlemminger, L Perabo, D Goldnau, J Endell, ... Journal of virology 79 (18), 11776-11787, 2005 | 217 | 2005 |
| Toll‐like receptor 2–mediated innate immune response in human nonparenchymal liver cells toward adeno‐associated viral vectors M Hösel, M Broxtermann, H Janicki, K Esser, S Arzberger, P Hartmann, ... Hepatology 55 (1), 287-297, 2012 | 216 | 2012 |
| Displaying high-affinity ligands on adeno-associated viral vectors enables tumor cell-specific and safe gene transfer RC Münch, H Janicki, I Völker, A Rasbach, M Hallek, H Büning, ... Molecular therapy 21 (1), 109-118, 2013 | 210 | 2013 |
| A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses A Neerincx, K Lautz, M Menning, E Kremmer, P Zigrino, M Hösel, ... Journal of Biological Chemistry 285 (34), 26223-26232, 2010 | 210 | 2010 |
| Combinatorial engineering of a gene therapy vector: directed evolution of adeno‐associated virus L Perabo, J Endell, S King, K Lux, D Goldnau, M Hallek, H Büning The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2006 | 181 | 2006 |
| Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses LM Work, H Büning, E Hunt, SA Nicklin, L Denby, N Britton, K Leike, ... Molecular therapy 13 (4), 683-693, 2006 | 177 | 2006 |
| Receptor targeting of adeno-associated virus vectors H Büning, MU Ried, L Perabo, FM Gerner, NA Huttner, J Enssle, M Hallek Gene therapy 10 (14), 1142-1151, 2003 | 175 | 2003 |
| Adeno-associated virus capsids displaying immunoglobulin-binding domains permit antibody-mediated vector retargeting to specific cell surface receptors MU Ried, A Girod, K Leike, H Büning, M Hallek Journal of virology 76 (9), 4559-4566, 2002 | 175 | 2002 |
| Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies NA Huttner, A Girod, L Perabo, D Edbauer, JA Kleinschmidt, H Büning, ... Gene therapy 10 (26), 2139-2147, 2003 | 168 | 2003 |
